1. Home
  2. RES vs TRVI Comparison

RES vs TRVI Comparison

Compare RES & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RPC Inc.

RES

RPC Inc.

HOLD

Current Price

$6.95

Market Cap

1.6B

Sector

Energy

ML Signal

HOLD

Logo Trevi Therapeutics Inc.

TRVI

Trevi Therapeutics Inc.

HOLD

Current Price

$14.29

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RES
TRVI
Founded
1984
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.4B
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
RES
TRVI
Price
$6.95
$14.29
Analyst Decision
Hold
Strong Buy
Analyst Count
5
11
Target Price
$5.64
$21.55
AVG Volume (30 Days)
2.2M
1.8M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
2.02%
N/A
EPS Growth
N/A
31.91
EPS
N/A
N/A
Revenue
$41,919,000,000.00
N/A
Revenue This Year
$3.29
N/A
Revenue Next Year
$4.05
N/A
P/E Ratio
$45.40
N/A
Revenue Growth
2216.21
N/A
52 Week Low
$4.18
$5.38
52 Week High
$8.16
$16.12

Technical Indicators

Market Signals
Indicator
RES
TRVI
Relative Strength Index (RSI) 44.46 51.15
Support Level $6.42 $10.07
Resistance Level $7.41 $16.12
Average True Range (ATR) 0.27 0.80
MACD -0.11 -0.05
Stochastic Oscillator 10.32 40.11

Price Performance

Historical Comparison
RES
TRVI

About RES RPC Inc.

RPC Inc is an oilfield services company. It provides specialized oilfield services and equipment to independent and oil and gas companies engaged in the exploration, production, and development of oil and gas properties throughout the United States. Its operating segment includes Technical Services and Support Services. The Technical Services segment, which generates maximum revenue, comprises service lines that generate revenue based on equipment, personnel, or materials at the well site and are closely aligned with completion and production activities of the customers. The Support Services segment comprises service lines that generate revenue from services and equipment offered off the well site and are closely aligned with the customers' drilling activities.

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.

Share on Social Networks: